Peer-reviewed articles

Coebergh JW, van den Hurk C, Rosso S, et al. EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluation. Eur J Cancer. 2015;51(9):997-1017. doi:10.1016/j.ejca.2015.02.018

O’Connor M, Gallagher P, Waller J, et al. Adverse psychological outcomes following colposcopy and related procedures: a systematic review. BJOG: Int J Obstet Gy. 2015;123(1):24-38. doi:10.1111/1471-0528.13462

Sharp L, O’Leary E, Kinnear H, Gavin A, Drummond FJ. Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study. Psycho-Oncology. 2015;25(3):282-291. doi:10.1002/pon.3909

Sharp L, Timmons A. Pre-diagnosis employment status and financial circumstances predict cancer-related financial stress and strain among breast and prostate cancer survivors. Support Care Cancer. Published online July 5, 2015:1-11. doi:10.1007/s00520-015-2832-4

Allemani C, Coleman MP. Cancer survival: the CONCORD-2 study – Authors’ reply. The Lancet. 2015;386(9992):429-430. doi:10.1016/S0140-6736(15)61443-X

Pearce AM, Ryan F, Drummond FJ, Thomas AA, Timmons A, Sharp L. Comparing the costs of three prostate cancer follow-up strategies: a cost minimisation analysis. Support Care Cancer. Published online August 6, 2015:1-8. doi:10.1007/s00520-015-2857-8

O’Connor M, Waller J, Gallagher P, et al. Understanding Women’s Differing Experiences of Distress after Colposcopy: A Qualitative Interview Study. Women’s Health Issues. 2015;25(5):528-534. doi:10.1016/j.whi.2015.05.009

Anderson LA, Tavilla A, Brenner H, et al. Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5. European Journal of Cancer. 2015;51(15):2144-2157. doi:10.1016/j.ejca.2015.07.026

Baili P, Di Salvo F, Marcos-Gragera R, et al. Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study. European Journal of Cancer. 2015;51(15):2120-2129. doi:10.1016/j.ejca.2015.07.025

Breckenridge K, Bekker HL, Gibbons E, et al. How to routinely collect data on patient-reported outcome and experience measures in renal registries in Europe: an expert consensus meeting. Nephrol Dial Transplant. 2015;30(10):1605-1614. doi:10.1093/ndt/gfv209

Crocetti E, Mallone S, Robsahm TE, et al. Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study. European Journal of Cancer. 2015;51(15):2179-2190. doi:10.1016/j.ejca.2015.07.039

De Angelis R, Minicozzi P, Sant M, et al. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000–2007: Results of EUROCARE-5 population-based study. European Journal of Cancer. 2015;51(15):2254-2268. doi:10.1016/j.ejca.2015.08.003

Francisci S, Minicozzi P, Pierannunzio D, et al. Survival patterns in lung and pleural cancer in Europe 1999–2007: Results from the EUROCARE-5 study. European Journal of Cancer. 2015;51(15):2242-2253. doi:10.1016/j.ejca.2015.07.033

Gatta G, Botta L, Sánchez MJ, et al. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. European Journal of Cancer. 2015;51(15):2130-2143. doi:10.1016/j.ejca.2015.07.043

Holleczek B, Rossi S, Domenic A, et al. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 study. European Journal of Cancer. 2015;51(15):2158-2168. doi:10.1016/j.ejca.2015.07.024

Lepage C, Capocaccia R, Hackl M, et al. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: Results of EUROCARE-5. European Journal of Cancer. 2015;51(15):2169-2178. doi:10.1016/j.ejca.2015.07.034

Marcos-Gragera R, Mallone S, Kiemeney LA, et al. Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5. European Journal of Cancer. 2015;51(15):2217-2230. doi:10.1016/j.ejca.2015.07.028

Rossi S, Baili P, Capocaccia R, et al. The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods. European Journal of Cancer. 2015;51(15):2104-2119. doi:10.1016/j.ejca.2015.08.001

Sant M, Chirlaque Lopez MD, Agresti R, et al. Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study. European Journal of Cancer. 2015;51(15):2191-2205. doi:10.1016/j.ejca.2015.07.022

Sharp L, Cotton SC, Cruickshank ME, et al. Long-Term Worries after Colposcopy: Which Women Are at Increased Risk? Womens Health Issues. 2015;25(5):517-527. doi:10.1016/j.whi.2015.04.002

Trama A, Foschi R, Larrañaga N, et al. Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: Results from the EUROCARE-5 study. European Journal of Cancer. 2015;51(15):2206-2216. doi:10.1016/j.ejca.2015.07.027

Visser O, Ardanaz E, Botta L, et al. Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study. European Journal of Cancer. 2015;51(15):2231-2241. doi:10.1016/j.ejca.2015.07.032

Brown C, Barron TI, Bennett K, MacDonald D, Dwane F, Sharp L. Generalisability of pharmacoepidemiological studies using restricted prescription data. Ir J Med Sci. Published online October 6, 2015:1-5. doi:10.1007/s11845-015-1360-z

Cahir C, Dombrowski SU, Kelly CM, Kennedy MJ, Bennett K, Sharp L. Women’s experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour. Support Care Cancer. 2015;23(11):3115-3130. doi:10.1007/s00520-015-2685-x

Comber H, De Camargo Cancela M, Haase T, Johnson H, Sharp L, Pratschke J. Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin’s Lymphoma. PLoS One. 2016;11(12):e0168684. doi:10.1371/journal.pone.0168684